News Agency
Men's Weekly

Telix Granted FDA Orphan Drug Designation for Bone Marrow Conditioning Treatment

  • Written by PR Newswire
Telix Granted FDA Orphan Drug Designation for Bone Marrow Conditioning Treatment

MELBOURNE, Australia and INDIANAPOLIS, March 29, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for TLX66 (90Y-besilesomab), for conditioning treatment prior to hematopoietic stem cell...

Read more: Telix Granted FDA Orphan Drug Designation for Bone Marrow Conditioning Treatment

Understanding Your Rights Around Property After Separation

Property division is one of the most significant financial matters that arises when a relationship ends, and it's also one of the most commonly misunderstood. Many people assume that assets are simply divided equally, but the reality under Australian family... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion